{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T10:33:45Z","timestamp":1771497225415,"version":"3.50.1"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>KCa3.1 has been suggested to be involved in regulating cell activation, proliferation, and migration in multiple cell types, including airway inflammatory and structural cells. However, the contributions of KCa3.1 to airway inflammation and remodeling and subsequent airway hyperresponsiveness (AHR) in allergic asthma remain to be explored. The main purpose of this study was to elucidate the roles of KCa3.1 and the potential therapeutic value of KCa3.1 blockers in chronic allergic asthma. Using real-time PCR, Western blotting, or immunohistochemical analyses, we explored the precise role of KCa3.1 in the bronchi of allergic mice and asthmatic human bronchial smooth muscle cells (BSMCs). We found that KCa3.1 mRNA and protein expression were elevated in the bronchi of allergic mice, and double labeling revealed that up-regulation occurred primarily in airway smooth muscle cells. Triarylmethane (TRAM)\u201334, a KCa3.1 blocker, dose-dependently inhibited the generation and maintenance of the ovalbumin-induced airway inflammation associated with increased Th2-type cytokines and decreased Th1-type cytokine, as well as subepithelial extracellular matrix deposition, goblet-cell hyperplasia, and AHR in a murine model of asthma. Moreover, the pharmacological blockade and gene silencing of KCa3.1, which was evidently elevated after mitogen stimulation, suppressed asthmatic human BSMC proliferation and migration, and arrested the cell cycle at the G0\/G1 phase. In addition, the KCa3.1 activator 1-ethylbenzimidazolinone\u2013induced membrane hyperpolarization and intracellular calcium increase in asthmatic human BSMCs were attenuated by TRAM-34. We demonstrate for the first time an important role for KCa3.1 in the pathogenesis of airway inflammation and remodeling in allergic asthma, and we suggest that KCa3.1 blockers may represent a promising therapeutic strategy for asthma.<\/jats:p>","DOI":"10.1165\/rcmb.2012-0236oc","type":"journal-article","created":{"date-parts":[[2013,3,15]],"date-time":"2013-03-15T04:09:02Z","timestamp":1363320542000},"page":"685-693","source":"Crossref","is-referenced-by-count":39,"title":["Targeted Inhibition of KCa3.1 Channel Attenuates Airway Inflammation and Remodeling in Allergic Asthma"],"prefix":"10.1093","volume":"48","author":[{"given":"Zhi-Hua","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, China; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Rong","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, China; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Xia","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, China; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-Ni","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, China; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zu-Peng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, China; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, China; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-Zheng","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Yao","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, China; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Zhuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, China; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,6,1]]},"reference":[{"key":"2026021904205716800_bib1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejphar.2011.12.020","article-title":"Regulatory role of antigen-induced interleukin-10, produced by CD4(+) T cells, in airway neutrophilia in a murine model for asthma","volume":"677","author":"Nabe","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"2026021904205716800_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2172-13-6","article-title":"Adoptive transfer of IL-4R\u03b1+ macrophages is sufficient to enhance eosinophilic inflammation in a mouse model of allergic lung inflammation","volume":"13","author":"Ford","year":"2012","journal-title":"BMC Immunol"},{"key":"2026021904205716800_bib3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1440-1843.2011.02097.x","article-title":"Role of neutrophils in persistent airway obstruction due to refractory asthma","volume":"17","author":"Choi","year":"2012","journal-title":"Respirology"},{"key":"2026021904205716800_bib4","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1164\/rccm.200909-1350OC","article-title":"Exposure to mycotoxins increases the allergic immune response in a murine asthma model","volume":"181","author":"Sch\u00fctze","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021904205716800_bib5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2222.2004.01895.x","article-title":"Prolonged allergen challenge in mice leads to persistent airway remodelling","volume":"34","author":"McMillan","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"2026021904205716800_bib6","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1164\/rccm.201110-1849OC","article-title":"Airway smooth muscle hypertrophy and hyperplasia in asthma","volume":"185","author":"James","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021904205716800_bib7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.7326\/0003-4819-139-5_Part_1-200309020-00012","article-title":"How do corticosteroids work in asthma?","volume":"139","author":"Barnes","year":"2003","journal-title":"Ann Intern Med"},{"key":"2026021904205716800_bib8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jaci.2006.01.032","article-title":"Update on glucocorticoid action and resistance","volume":"117","author":"Ito","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"2026021904205716800_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1398-9995.2004.00772.x","article-title":"Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 Step 4 treatment): INNOVATE","volume":"60","author":"Humbert","year":"2005","journal-title":"Allergy"},{"key":"2026021904205716800_bib10","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jaci.2006.11.702","article-title":"Severe asthma in adults: what are the important questions?","volume":"119","author":"Chanez","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"2026021904205716800_bib11","doi-asserted-by":"crossref","first-page":"37137","DOI":"10.1074\/jbc.M003941200","article-title":"Up-regulation of the IKCa1 potassium channel during T-cell activation: molecular mechanism and functional consequences","volume":"275","author":"Ghanshani","year":"2000","journal-title":"J Biol Chem"},{"key":"2026021904205716800_bib12","doi-asserted-by":"crossref","first-page":"8040","DOI":"10.4049\/jimmunol.180.12.8040","article-title":"Blunted IgE-mediated activation of mast cells in mice lacking the Ca(2+)-activated K(+) channel K(Ca)3.1","volume":"180","author":"Shumilina","year":"2008","journal-title":"J Immunol"},{"key":"2026021904205716800_bib13","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1096\/fasebj.14.10.1362","article-title":"Involvement of the epidermal growth factor receptor in epithelial repair in asthma","volume":"14","author":"Puddicombe","year":"2000","journal-title":"FASEB J"},{"key":"2026021904205716800_bib14","doi-asserted-by":"crossref","first-page":"C104","DOI":"10.1152\/ajpcell.1991.260.1.C104","article-title":"Ca2(+)-activated K+ current in Ras-transformed fibroblasts is absent from nontransformed cells","volume":"260","author":"Rane","year":"1991","journal-title":"Am J Physiol Cell Physiol"},{"key":"2026021904205716800_bib15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1165\/rcmb.2006-0358OC","article-title":"KCa3.1 Ca2+-activated K+ channels regulate human airway smooth muscle proliferation","volume":"37","author":"Shepherd","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026021904205716800_bib16","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/j.1476-5381.2009.00362.x","article-title":"The K+ channels K(Ca)3.1 and K(v)1.3 as novel targets for asthma therapy","volume":"157","author":"Bradding","year":"2009","journal-title":"Br J Pharmacol"},{"key":"2026021904205716800_bib17","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jaci.2011.07.047","article-title":"Functional KCa3.1 K+ channels are required for human fibrocyte migration","volume":"128","author":"Cruse","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"2026021904205716800_bib18","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1172\/JCI30836","article-title":"The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans","volume":"118","author":"Toyama","year":"2008","journal-title":"J Clin Invest"},{"key":"2026021904205716800_bib19","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/eji.200425954","article-title":"Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice","volume":"35","author":"Reich","year":"2005","journal-title":"Eur J Immunol"},{"key":"2026021904205716800_bib20","doi-asserted-by":"crossref","first-page":"C285","DOI":"10.1152\/ajpcell.00418.2008","article-title":"Inhibition of the KCa3.1 channels by AMP-activated protein kinase in human airway epithelial cells","volume":"296","author":"Klein","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"2026021904205716800_bib21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cytogfr.2004.03.007","article-title":"The PDGF family: four gene products form five dimeric isoforms","volume":"15","author":"Fredriksson","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"2026021904205716800_bib22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/01.RES.0000238377.08219.0c","article-title":"Impaired endothelium-derived hyperpolarizing factor\u2013mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2+-activated K+ channel","volume":"99","author":"Si","year":"2006","journal-title":"Circ Res"},{"key":"2026021904205716800_bib23","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.ATV.0000156399.12787.5c","article-title":"Blockade of the intermediate-conductance Ca2+-activated K+ channel suppresses proliferation of microvascular and macrovascular endothelial cells and angiogenesis in vivo","volume":"25","author":"Grgic","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026021904205716800_bib24","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1161\/01.CIR.0000086464.04719.DD","article-title":"Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis","volume":"108","author":"K\u00f6hler","year":"2003","journal-title":"Circulation"},{"key":"2026021904205716800_bib25","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/ATVBAHA.107.155796","article-title":"Local delivery of the KCa3.1 blocker, TRAM-34, prevents acute angioplasty-induced coronary smooth muscle phenotypic modulation and limits stenosis","volume":"28","author":"Tharp","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026021904205716800_bib26","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2222.02193.x","article-title":"Therapeutic administration of budesonide ameliorates allergen-induced airway remodeling","volume":"35","author":"McMillan","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"2026021904205716800_bib27","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1164\/rccm.200807-1081OC","article-title":"Osteopontin deficiency protects against airway remodeling and hyperresponsiveness in chronic asthma","volume":"179","author":"Simoes","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021904205716800_bib28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1165\/rcmb.2007-0102OC","article-title":"NFAT1 transcription factor regulates pulmonary allergic inflammation and airway responsiveness","volume":"40","author":"Fonseca","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026021904205716800_bib29","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1365-2222.2001.01078.x","article-title":"Cytokine mRNA expression in patients with mild allergic asthma following low dose or cumulative dose allergen provocation","volume":"31","author":"Prieto","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"2026021904205716800_bib30","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1164\/ajrccm.165.8.2106110","article-title":"Elevated levels of thymus- and activation-regulated chemokine in bronchoalveolar lavage fluid from patients with eosinophilic pneumonia","volume":"165","author":"Miyazaki","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021904205716800_bib31","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.1073\/pnas.93.15.7821","article-title":"Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity","volume":"93","author":"Rankin","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026021904205716800_bib32","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1126\/science.282.5397.2258","article-title":"Interleukin-13: central mediator of allergic asthma","volume":"282","author":"Wills-Karp","year":"1998","journal-title":"Science"},{"key":"2026021904205716800_bib33","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/362245a0","article-title":"Disruption of the murine IL-4 gene blocks Th2 cytokine responses","volume":"362","author":"Kopf","year":"1993","journal-title":"Nature"},{"key":"2026021904205716800_bib34","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4049\/jimmunol.165.1.108","article-title":"Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity","volume":"165","author":"Webb","year":"2000","journal-title":"J Immunol"},{"key":"2026021904205716800_bib35","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1074-7613(00)80414-8","article-title":"Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha\u2013deficient mice","volume":"4","author":"Yoshida","year":"1996","journal-title":"Immunity"},{"key":"2026021904205716800_bib36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.0105-2896.2004.00215.x","article-title":"Interleukin-13 in asthma pathogenesis","volume":"202","author":"Wills-Karp","year":"2004","journal-title":"Immunol Rev"},{"key":"2026021904205716800_bib37","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1476-5381.1995.tb15926.x","article-title":"Potassium currents in human freshly isolated bronchial smooth muscle cells","volume":"115","author":"Snetkov","year":"1995","journal-title":"Br J Pharmacol"},{"key":"2026021904205716800_bib38","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1586\/ecp.10.11","article-title":"Therapeutic potential of KCa3.1 blockers: recent advances and promising trends","volume":"3","author":"Wulff","year":"2010","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2026021904205716800_bib39","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1165\/rcmb.2012-0103OC","article-title":"The KCa3.1 blocker TRAM-34 attenuates airway remodeling and eosinophilia in a mouse asthma model","volume":"48","author":"Girodet","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026021904205716800_bib40","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1073\/pnas.0910133107","article-title":"Inhibition of the K+ channel KCa3.1 ameliorates T cell\u2013mediated colitis","volume":"107","author":"Di","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026021904205716800_bib41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000095135","article-title":"Expression and modulation of the intermediate-conductance Ca2+-activated K+ channel in glioblastoma GL-15 cells","volume":"18","author":"Fioretti","year":"2006","journal-title":"Cell Physiol Biochem"},{"key":"2026021904205716800_bib42","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1124\/mol.65.3.630","article-title":"Blockage of intermediate-conductance Ca2+-activated K+ channels inhibit human pancreatic cancer cell growth in vitro","volume":"65","author":"J\u00e4ger","year":"2004","journal-title":"Mol Pharmacol"},{"key":"2026021904205716800_bib43","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1038\/sj.onc.1210308","article-title":"Blockage of intermediate-conductance\u2013Ca2+-activated K+ channels inhibits progression of human endometrial cancer","volume":"26","author":"Wang","year":"2007","journal-title":"Oncogene"},{"key":"2026021904205716800_bib44","doi-asserted-by":"crossref","first-page":"F227","DOI":"10.1152\/ajprenal.00057.2007","article-title":"Ca2+ dependence of flow-stimulated K secretion in the mammalian cortical collecting duct","volume":"293","author":"Liu","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026021904205716800_bib45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s002329900135","article-title":"Potassium channels, proliferation and G1 progression","volume":"154","author":"Wonderlin","year":"1996","journal-title":"J Membr Biol"},{"key":"2026021904205716800_bib46","doi-asserted-by":"crossref","first-page":"47681","DOI":"10.1074\/jbc.M409627200","article-title":"Physiological roles of the intermediate conductance, Ca2+-activated potassium channel KCNN4","volume":"279","author":"Begenisich","year":"2004","journal-title":"J Biol Chem"},{"key":"2026021904205716800_bib47","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1124\/jpet.111.182782","article-title":"Intermediate-conductance Ca2+-activated K+ channel, KCa3.1, as a novel therapeutic target for benign prostatic hyperplasia","volume":"338","author":"Ohya","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"2026021904205716800_bib48","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1182\/blood-2007-08-110098","article-title":"Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia","volume":"111","author":"Ataga","year":"2008","journal-title":"Blood"}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/48\/6\/685\/66896836\/ajrcmb_48_6_685.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/48\/6\/685\/66896836\/ajrcmb_48_6_685.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T09:24:11Z","timestamp":1771493051000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/48\/6\/685\/8483420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,1]]},"references-count":48,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,6,1]]},"published-print":{"date-parts":[[2013,6,1]]}},"URL":"https:\/\/doi.org\/10.1165\/rcmb.2012-0236oc","relation":{},"ISSN":["1044-1549","1535-4989"],"issn-type":[{"value":"1044-1549","type":"print"},{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,6]]},"published":{"date-parts":[[2013,6,1]]}}}